Nikolis Andreas, Bernstein Steven, Kinney Brian, Scuderi Nicolo, Rastogi Shipra, Sampalis John S
Victoria Park, Plastic Surgery Section, Westmount, QC, Canada.
Dermatology Department, University of Montreal Health Centre, Montreal, QC, Canada.
Clin Cosmet Investig Dermatol. 2016 May 13;9:115-25. doi: 10.2147/CCID.S100697. eCollection 2016.
Many treatment modalities exist to counteract the effects of cutaneous aging. Ablative methods have been the mainstay for nonsurgical facial rejuvenation. In recent years, nonablative techniques have been developed with the aim of achieving facial rejuvenation without epidermal damage. Light-emitting diode (LED) photorejuvenation is a novel nonablative technique that induces collagen synthesis through biophotomodulatory pathways.
A single-center, randomized, single-blinded, placebo-controlled, split-faced clinical trial was designed. Thirty-two patients were enrolled for a 12-week study. Patients were randomized into one of four groups: Group A, treatment with KLOX-001 gel formulation and white LED (placebo) light; Group B, treatment with a placebo/base gel (no active chromophore) formulation and KLOX LED light; Group C, treatment with KLOX-001 gel formulation and KLOX LED light; and Group D, treatment with the standard skin rejuvenating treatment (0.1% retinol-based cream). Patients received treatment at weeks 0, 1, 2, and 3, and returned to the clinic at weeks 4, 8, and 12 for clinical assessments performed by an independent, blinded committee of physicians using subjective clinician assessment scales. Tolerability, adverse outcomes, and patient satisfaction were also assessed.
Analysis demonstrated that the KLOX LED light with KLOX placebo/base gel and the KLOX LED light + KLOX-001 gel formulation groups were superior to standard of care and KLOX-001 gel formulation with placebo light on subjective clinical assessment and multiple wrinkle scales, with statistically significant results obtained for brow positioning, perioral wrinkling, and total wrinkle score.
The study results show that KLOX LED light with KLOX-001 gel formulation and KLOX LED light with KLOX placebo/base gel are effective, safe, well-tolerated, and painless treatment modalities for skin rejuvenation.
存在多种治疗方式来对抗皮肤老化的影响。剥脱性方法一直是非手术面部年轻化的主要手段。近年来,为了在不损伤表皮的情况下实现面部年轻化,人们开发了非剥脱性技术。发光二极管(LED)光嫩肤是一种新型非剥脱性技术,它通过生物光调制途径诱导胶原蛋白合成。
设计了一项单中心、随机、单盲、安慰剂对照、半脸临床试验。32名患者参与了为期12周的研究。患者被随机分为四组之一:A组,使用KLOX - 001凝胶制剂和白色LED(安慰剂)光进行治疗;B组,使用安慰剂/基础凝胶(无活性发色团)制剂和KLOX LED光进行治疗;C组,使用KLOX - 001凝胶制剂和KLOX LED光进行治疗;D组,使用标准皮肤年轻化治疗(0.1%视黄醇基乳膏)进行治疗。患者在第0、1、2和3周接受治疗,并在第4、8和12周返回诊所,由一个独立的、盲法的医生委员会使用主观临床评估量表进行临床评估。还评估了耐受性、不良后果和患者满意度。
分析表明,在主观临床评估和多个皱纹量表上,使用KLOX安慰剂/基础凝胶的KLOX LED光组以及KLOX LED光 + KLOX - 001凝胶制剂组优于标准护理组和使用安慰剂光的KLOX - 001凝胶制剂组,在眉位、口周皱纹和总皱纹评分方面获得了具有统计学意义的结果。
研究结果表明,使用KLOX - 001凝胶制剂的KLOX LED光以及使用KLOX安慰剂/基础凝胶的KLOX LED光是有效、安全、耐受性良好且无痛的皮肤年轻化治疗方式。